Further studies on the synthesis of A-form monoamine oxidase - PubMed (original) (raw)
Further studies on the synthesis of A-form monoamine oxidase
T Egashira et al. Jpn J Pharmacol. 1981 Oct.
Free article
Abstract
The relation between precursors and restoration of A-form MAO activity in rat liver after administration of clorgyline to rats was investigated by measuring the rates of recovery of A-form MAO activity after treatment with the inhibitor. The half-lives of mitochondrial and microsomal A-form MAO were estimated as 3.5 and 2.0 days, respectively. MAO activity and the amount of MAO molecules were completely restored within 14 days. However the values attained did not exceed the control values in a period of 14 days. Clorgyline plus cycloheximide or chloramphenicol did not prevent the recovery of MAO activity in the microsomes, but did not delay the appearance of enzyme activity in the mitochondria. A and B-form-like MAO were also observed in the microsomal and supernatant fractions, with clorgyline as inhibitor. These results suggest that the microsomal enzyme is a precursor of the mitochondrial enzyme, that the levels of A-form and B-form MAO are regulated genetically, and that the two forms of MAO may be synthesized separately.
Similar articles
- Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.
Lenzen S, Nahrstedt H, Panten U. Lenzen S, et al. Naunyn Schmiedebergs Arch Pharmacol. 1983 Nov;324(3):190-5. doi: 10.1007/BF00503893. Naunyn Schmiedebergs Arch Pharmacol. 1983. PMID: 6419132 - Preferential inhibition of the B-form of monoamine oxidase in the liver of rats given 3'-methyl-4-dimethylaminoazobenzene in the diet.
Egashira T, Yamamoto T, Yamanaka Y, Kuroiwa Y. Egashira T, et al. Biochem Pharmacol. 1982 Apr 1;31(7):1301-7. doi: 10.1016/0006-2952(82)90020-x. Biochem Pharmacol. 1982. PMID: 6807318 - Formation of the neurotransmitter glycine from the anticonvulsant milacemide is mediated by brain monoamine oxidase B.
Janssens de Varebeke P, Cavalier R, David-Remacle M, Youdim MB. Janssens de Varebeke P, et al. J Neurochem. 1988 Apr;50(4):1011-6. doi: 10.1111/j.1471-4159.1988.tb10566.x. J Neurochem. 1988. PMID: 3346666 - Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
Lamensdorf I, Youdim MB, Finberg JP. Lamensdorf I, et al. J Neurochem. 1996 Oct;67(4):1532-9. doi: 10.1046/j.1471-4159.1996.67041532.x. J Neurochem. 1996. PMID: 8858937 - Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives.
Inoue H, Castagnoli K, Van Der Schyf C, Mabic S, Igarashi K, Castagnoli N Jr. Inoue H, et al. J Pharmacol Exp Ther. 1999 Nov;291(2):856-64. J Pharmacol Exp Ther. 1999. PMID: 10525109
Cited by
- Structure and promoter organization of the human monoamine oxidase A and B genes.
Shih JC, Grimsby J, Chen K, Zhu QS. Shih JC, et al. J Psychiatry Neurosci. 1993 Jan;18(1):25-32. J Psychiatry Neurosci. 1993. PMID: 8461277 Free PMC article. - Monoamine oxidase inactivation: from pathophysiology to therapeutics.
Bortolato M, Chen K, Shih JC. Bortolato M, et al. Adv Drug Deliv Rev. 2008 Oct-Nov;60(13-14):1527-33. doi: 10.1016/j.addr.2008.06.002. Epub 2008 Jul 4. Adv Drug Deliv Rev. 2008. PMID: 18652859 Free PMC article. Review. - The role of the serotonergic system at the interface of aggression and suicide.
Bortolato M, Pivac N, Muck Seler D, Nikolac Perkovic M, Pessia M, Di Giovanni G. Bortolato M, et al. Neuroscience. 2013 Apr 16;236:160-85. doi: 10.1016/j.neuroscience.2013.01.015. Epub 2013 Jan 16. Neuroscience. 2013. PMID: 23333677 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources